The below Parliamentary question was asked by Andrew Gwynne on 2016-02-01.
To ask Mr Chancellor of the Exchequer, whether his Department has made an assessment of the effect of the patent box tax arrangement on the economy.
Mr David Gauke
The information is not held in the form requested. The estimated amounts of Patent Box relief can be found at the link below:
“
The below Parliamentary question was asked by Andrew Gwynne on 2016-02-05.
To ask the Secretary of State for Health, how much his Department has paid out in compensation to (a) internal and (b) external claimants in each year since 2010.
Alistair Burt
The value of compensation payments made in each year since 2010* is outlined in the table below.
|
Year Compensation paid |
Value of compensation paid to external claimants |
Value of compensation paid to internal claimants |
|
2014/15 |
£211,000 |
£173,750 |
|
2013/14 |
£3,648 |
£0 |
|
2012/13 |
£17,825 |
£250 |
|
2011/12 |
£0 |
£0 |
|
2010/11 |
£0 |
£0 |
*2015/16 data is still being audited and will be available when the final accounts are published later this year.
The below Parliamentary question was asked by Andrew Gwynne on 2016-02-22.
To ask the Secretary of State for Health, with reference to the report of the independent cancer taskforce, Achieving world class cancer outcomes: A strategy for England 2015-2020, published in July 2015, what progress has been made in developing a new tobacco control strategy.
Jane Ellison
The development of a new tobacco control plan for England is currently in progress and will be published later this year. The recommendations of the Independent Cancer Taskforce will be considered alongside this work.
The below Parliamentary question was asked by Andrew Gwynne on 2016-02-23.
To ask the Secretary of State for Health, what assessment he has made of the effect on NHS (a) services and (b) governance of NHS England’s decision to discontinue the role of national clinical director for neurology services from March 2016; and if he will make a statement.
Jane Ellison
Sir Bruce Keogh, NHS England’s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result of the review, NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future.
Where there will no longer be a specific NCD role, NHS England will secure expert clinical advice from its clinical networks and through its relationships with professional bodies and by appointing clinical advisors. For neurology it is planned that access to advice will be through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges. It is expected that these new arrangements will be in place from 1 April 2016.
The below Parliamentary question was asked by Andrew Gwynne on 2016-03-08.
To ask the Secretary of State for Health, how many organisations have withdrawn from the Responsibility Deal since May 2015.
Jane Ellison
Two organisations have withdrawn from the Responsibility Deal since May 2015.
Information about the Deal and the partners that have signed up to it can be found at:
https://responsibilitydeal.dh.gov.uk/
“
The below Parliamentary question was asked by Andrew Gwynne on 2016-03-21.
To ask the Secretary of State for Health, if he will make it his Department’s policy to ensure that brain tumour symptom cards are distributed to child health clinics and health visitors.
Jane Ellison
The Department has highlighted the value of the Headsmart awareness raising materials with Directors of Public Health, health visitors and school nurses, to encourage their use by professionals in signposting to specialist advice if needed. The Department and Public Health England will continue to liaise with health professionals to increase awareness of brain tumours.
The below Parliamentary question was asked by Andrew Gwynne on 2016-03-23.
To ask the Secretary of State for Health, pursuant to the Answer of 27 January 2016 to Question 23756, what assessment his Department has made of the adequacy of funds within NHS organisations to eradicate backlog maintenance repairs which are considered to be high risk.
George Freeman
National Health Service organisations are locally responsible for the quality of their estate and the management of their own backlog maintenance. They decide on the investment needed to reduce backlog maintenance levels based on their own local plans and financial situation. Capital investment by NHS providers continues to be financed locally through income and/or through access to external financing.
The below Parliamentary question was asked by Andrew Gwynne on 2016-05-03.
To ask the Secretary of State for Health, whether data other than the most recent National Diet and Nutrition Survey data is being used in the development of the childhood obesity strategy.
Jane Ellison
The Childhood Obesity Strategy will draw from a range of the latest data and evidence, including from Public Health England and other partners.
The below Parliamentary question was asked by Andrew Gwynne on 2016-05-18.
To ask the Secretary of State for Health, how many times the Mental Capacity Act 2005 has been found to have been wrongly applied to exclude a relative of a resident from visiting a care home.
Alistair Burt
The information requested is not collected centrally.
The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.
To ask the Secretary of State for Health, what recent guidance his Department published to commissioners on meeting excess treatment costs for clinical trials.
George Freeman
In November 2015, NHS England published new guidance to help clarify the rules and expectations on the funding of excess treatment costs incurred during a non-commercial research study. The guidance is provided for clinical commissioning groups and commissioners of specialised services.